CRISPR/Cas9 genome editing to treat sickle cell disease
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Автор: | Ullah, Mohammad |
---|---|
Інші автори: | Islam, Farzana |
Формат: | Дисертація |
Мова: | English |
Опубліковано: |
Brac University
2023
|
Предмети: | |
Онлайн доступ: | http://hdl.handle.net/10361/19355 |
Схожі ресурси
-
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
за авторством: Maria, Amatul
Опубліковано: (2020) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
за авторством: Shaikat, Mahdi Mubin
Опубліковано: (2023) -
A review on CRISPR-Cas system based applications in Oncology
за авторством: Sadia, Mir
Опубліковано: (2022) -
A review on CRISPR Technology as an Antiviral Tool
за авторством: Srishti, Sanjida Ahmed
Опубліковано: (2023) -
CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
за авторством: Eva, Israt Ara Jannat
Опубліковано: (2023)